Ampio Updates Regulatory Status for Ampion

ENGLEWOOD, Colo., March 6, 2019 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today updates the regulatory status of Ampion. Food and Drug Administration (FDA) provided guidance that Ampio should complete an... Biopharmaceuticals, FDA Ampio Pharmaceuticals, Ampion, osteoarthritis

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2044819

Source: HSMN NewsFeed - March 6, 2019 Category: Pharmaceuticals Source Type: news

More News: Food and Drug Administration (FDA) | Marketing | Osteoarthritis | Pharmaceuticals